Share-based Compensation (Tables)

9 Months Ended

Dec. 31, 2021

Share-based Payment Arrangement [Abstract]

Summary of Activity for Stock Options

The following table summarizes activity for stock options during the period ended December 31, 2021:

	Number of Options	Weighted Average Exercise Price		Weighted Average Remaining Contractual Term	Aggregate Intrinsic Value
	(in thousands)	(per share)		(years)	(in thousands)
Balance, March 31, 2021	8,393	$	21.31	8.6	$	226,438
Granted	115	52.86
Exercised	(1,170)	20.22
Forfeited	(244)	25.05
Balance, December 31, 2021	7,094	$	21.87	7.8	$	272,958
Options vested and expected to vest at December 31, 2021	7,094	$	21.87	7.8	$	272,958
Options vested and exercisable at December 31, 2021	2,674	$	19.68	7.7	$	108,749

Summary of Activity for Restricted Shares

The following table provides a summary of the changes in the number of restricted stock awards (“RSAs”) and restricted stock units (“RSUs”) for the period ended December 31, 2021:

	Number of  RSAs	Weighted Average Grant Date Fair Value		Number of RSUs	Weighted Average Grant Date Fair Value
	(in thousands)	(per share)		(in thousands)	(per share)
Balance, March 31, 2021	728	$	16.00	3,041	$	24.44
Granted	—	—		3,269	51.29
Vested	(440)	16.00		(1,049)	24.24
Forfeited	(19)	16.00		(232)	33.51
Balance, December 31, 2021	269	$	16.00	5,029	$	41.52

Schedule of Share-based Compensation Expense

The following table summarizes the components of total share-based compensation expense included in the condensed consolidated financial statements for each period presented (in thousands):

	Three Months Ended December 31,				Nine Months Ended December 31,
	2021		2020		2021		2020
Cost of revenue	$	3,405	$	2,066	$	9,542	$	5,430
Research and development	5,908		3,259		15,331		8,666
Sales and marketing	9,267		6,480		26,487		18,007
General and administrative	8,543		3,783		20,590		10,988
Total share-based compensation	$	27,123	$	15,588	$	71,950	$	43,091